To examine radio frequency ablation as a treatment supplement to stimulate immunogenicity and improve survival for patients undergoing curative-intent surgery for colorectal liver metastases.
Patients with colorectal liver metastases planned for resection
At least one tumor size >=3cm
Performance status 0-1
Liver cirrhosis
Extrahepatic metastases that can not be addressed curatively
Other malignant diseases within 5 years prior to diagnosis
Prior RFA treatment
University of Aarhus
Lead sponsor
Aarhus University Hospital
Collaborator
Rigshospitalet, Denmark
Collaborator